The diverse findings on KYN metabolic abnormalities in depression suggest a possible mechanism by which the peripheral IFN activates IDO in the CNS, leading to increased QUIN levels in the brain and the subsequent activation of NMDA receptors. The gene discussed is IDO1; the disease is depressive disorder.